Aetiology, antimicrobial therapy and outcome of patients with community acquired severe sepsis: a prospective study in a Norwegian university hospital
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background: Severe sepsis is recognized as an inflammatory response causing organ dysfunction in patients with infection. Antimicrobial therapy is the mainstay of treatment. There is an ongoing demand for local surveillance of sepsis aetiology and monitoring of empirical treatment recommendations. The present study was established to describe the characteristics, quality of handling and outcome of patients with severe sepsis admitted to a Norwegian university hospital. Methods: A one year prospective, observational study of adult community acquired case-defined severe sepsis was undertaken. Demographics, focus of infection, microbiological findings, timing and adequacy of empirical antimicrobial agents were recorded. Clinical diagnostic practice was evaluated. Differences between categorical groups were analysed with Pearson’s chi-squared test. Predictors of in-hospital mortality were identified in a multivariate stepwise backward logistic regression model. Results: In total 220 patients were identified, yielding an estimated annual incidence of 0.5/1000 inhabitants. The focus of infection was established at admission in 69%. Respiratory tract infection was present in 52%, while genitourinary, soft tissue and abdominal infections each were found in 12-14%. Microbiological aetiology was identified in 61%; most prevalent were Streptococcus pneumoniae, Escherichia coli and Staphylococcus aureus. Independent predictors of in-hospital mortality were malignancy, cardiovascular disease, endocarditis, abdominal infections, undefined microbiological aetiology, delay in administration of empirical antimicrobial agents ≥ 6 hours and use of inadequate antimicrobial agents. In patients ≥ 75 years, antimicrobial therapy was less in compliance with current recommendations and more delayed. Conclusions: Community acquired severe sepsis is common. Initial clinical aetiology is often revised. Compliance with recommendations for empirical antimicrobial treatment is lowest in elderly patients. Our results emphasizes that quick identification of correct source of infection, proper sampling for microbiological analyses, and fast administration of adequate antimicrobial agents are crucial points in the management of severe sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 2×
“An increased risk of death has been demonstrated in patients with severe infection receiving inadequate antimicrobial therapy [6,7,35-37].”
BackgroundGaieski, D. F., Mikkelsen, M. E., Band, R. A., Pines, J. M., Massone, R., Furia, F. F., Shofer, F. S., & Goyal, M. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181cc4824 · Cited by 970 · cited 4×
“Some have demonstrated beneficial effects on survival with administration of antimicrobial therapy within the first hour [36,39].”
BackgroundInfluentialNECROTIZING FASCIITIS: CLINICAL PRESENTATION, MICROBIOLOGY, AND DETERMINANTS OF MORTALITY
WONG, C.-H., CHANG, H.-C., PASUPATHY, S., KHIN, L.-W., TAN, J.-L., & LOW, C.-O. (2003) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200308000-00005 · Cited by 909
Opal, S. M., Laterre, P.-F., Francois, B., LaRosa, S. P., Angus, D. C., Mira, J.-P., Wittebole, X., Dugernier, T., Perrotin, D., Tidswell, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.2194 · Cited by 812
(2004) · Intensive Care Medicine · doi:10.1007/s00134-003-2121-4 · Cited by 638 · cited 4×
“A likely pathogen has been found in 60-75% of eligible subjects in other studies on sepsis [5,6,13,19,24,31], comprising positive blood cultures within the range of 22-37% [5,6,12,19,30-33].”
BackgroundResultInfluentialEffectiveness of treatments for severe sepsis: A prospective, multicenter, observational study.
Ferrer, R., Artigas, A., Suarez, D., Palencia, E., Levy, M. M., Arenzana, A., Pérez, X. L., & Sirvent, J.-M. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200812-1912oc · Cited by 433
Puskarich, M. A., Trzeciak, S., Shapiro, N. I., Arnold, R. C., Horton, J. M., Studnek, J. R., Kline, J. A., & Jones, A. E. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821e87ab · Cited by 376
Heffner, A. C., Horton, J. M., Marchick, M. R., & Jones, A. E. (2010) · Clinical Infectious Diseases · doi:10.1086/650580 · Cited by 157
Cited by
Viale, P., Tedeschi, S., Scudeller, L., Attard, L., Badia, L., Bartoletti, M., Cascavilla, A., Cristini, F., Dentale, N., Fasulo, G., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix548 · Cited by 81
Yokota, P. K. O., Marra, A. R., Martino, M. D. V., Victor, E. S., Durão, M. S., Edmond, M. B., & dos Santos, O. F. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104475 · Cited by 85
“Recently, in a similar study evaluating etiology, antimicrobial therapy and outcome of patients with severe sepsis, quick identification of the source of infection, proper sampling for microbiological analyses, and the rapid administration of adequate antimicrobial therapy were shown to be crucial management points [2…”
BackgroundTang, F., Yuan, H., Li, X., & Qiao, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111616 · Cited by 48
Metadata
- Authors
- Nygård, S. T., Langeland, N., Flaatten, H. K., Fanebust, R., Haugen, O., & Skrede, S.
- Venue
- BMC Infectious Diseases
- Published
- 2014-03-04
- Volume
- 14
- Issue
- 1
- Pages
- 121-121
- ISSN
- 1471-2334 (ISSN-L)
- OpenAlex
- W2135645423
- Cited by
- 50
- References
- 8
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aetiology, antimicrobial therapy and outcome of patients with community acquired severe sepsis: a prospective study in a Norwegian university hospital. https://app.cochat.ai/papers/10.1186/1471-2334-14-121
- The paper
- Nygård, S. T., Langeland, N., Flaatten, H. K., Fanebust, R., Haugen, O., & Skrede, S. (2014). Aetiology, antimicrobial therapy and outcome of patients with community acquired severe sepsis: a prospective study in a Norwegian university hospital. BMC Infectious Diseases. https://doi.org/10.1186/1471-2334-14-121
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.